Valneva SE (VALN)
After hours:
| Previous close | 37.66 |
| Open | 36.11 |
| Bid | 35.00 x 1000 |
| Ask | 39.98 x 900 |
| Day's range | 34.83 - 36.17 |
| 52-week range | 24.16 - 67.84 |
| Volume | |
| Avg. volume | 94,877 |
| Market cap | 1.861B |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.06 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 65.43 |
- Zacks
Valneva (VALN) Up as COVID-19 Jab Neutralizes Omicron Variant
Three doses of Valneva's (VALN) inactivated COVID-19 vaccine candidate, VLA2001, neutralizes the Omicron variant of SARS-CoV-2, per data from preliminary lab studies. Shares rally.
- Globe Newswire
Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant
Preliminary laboratory studies demonstrate that three doses of Valneva’s inactivated COVID-19 vaccine candidate VLA2001 induced neutralization of the Omicron variant (B.1.1.529 lineage) 100% of tested serum samples presented neutralizing antibodies against the ancestral virus and Delta variant, and 87% against the Omicron variant Saint Herblain (France), January 19, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced results from an initial laborat
- Globe Newswire
VALNEVA Declaration of shares and voting rights - December 31, 2021
VALNEVA Declaration of shares and voting rights December 31, 2021 __________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment B Declaration date: January 6, 2022 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the changeDate on which this chang
